Johnson & Johnson, US4781601046

Johnson & Johnson Stock - Thursday technical picture and support levels

18.06.2026 - 16:51:09 | ad-hoc-news.de

Johnson & Johnson stock trades quietly after a muted week on Wall Street. With no fresh corporate headlines, investors are watching key technical levels and the broader healthcare sector for direction into the next earnings update.

Johnson & Johnson, US4781601046
Johnson & Johnson, US4781601046

Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 16:49 CET. Details in the imprint.

Johnson & Johnson (US4781601046) remains without major corporate news on Thursday. With no fresh filings or earnings releases, market attention turns to the stock’s technical setup and how it trades against key moving averages.

Go deeper

All news and key data on Johnson & Johnson stock

Track recent headlines, background and price data on Johnson & Johnson stock to put today’s quiet technical session into context.

What the charts show today

With no new Reuters, Bloomberg or company releases in the past trading day, the chart is the main reference point for Johnson & Johnson on Thursday. The stock recently traded modestly below its 52-week high after a relatively stable first half of the year.

On many trading platforms, Johnson & Johnson shares hover near their 50-day and 200-day moving averages, signaling a neutral medium-term trend. Volatility has remained muted compared with high-growth technology names in the Standard & Poor's 500 index.

How the stock trades versus peers

In the wider healthcare sector, large diversified names such as Johnson & Johnson often show steadier price patterns than biotech or smaller medtech stocks. This defensive profile can dampen sharp swings, especially around macro events like central bank decisions.

Against major US healthcare peers, Johnson & Johnson’s valuation metrics typically cluster in the mid-range on earnings multiples, reflecting its broad mix of pharmaceuticals, medical technology and consumer health heritage. That diversification remains a key reference point for many portfolio managers.

How the company makes money

Johnson & Johnson generates revenue primarily from prescription medicines, medical devices and, through its spin-offs and legacy brands, consumer health products. Flagship pharmaceutical therapies and surgical products are central profit drivers, supported by a global research and development and manufacturing footprint.

Where the stock trades today

The shares of Johnson & Johnson (US4781601046) trade on the New York Stock Exchange at $145.50 as of 06/18/2026, 16:30 ET.

Johnson & Johnson at a glance

  • Company: Johnson & Johnson Inc.
  • ISIN: US4781601046
  • WKN: 853260
  • Ticker: JNJ
  • Venue: NYSE
  • Price (as of 06/18/2026, 16:30 ET): 145.50 USD
  • Market cap: 350,000,000,000 USD (as of 06/18/2026)
  • Sector / Industry: Health Care / Pharmaceuticals & Medical Devices
  • Index membership: Dow Jones Industrial Average, S&P 500
  • Next earnings date: 07/18/2026

More on Johnson & Johnson stock on social media

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.

en | US4781601046 | JOHNSON & JOHNSON | boerse | 69573845 | bgmi